Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 23, 2023 - Issue 4
Submit an article Journal homepage
4,094
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical outcome data of chronic pain patients treated with cannabis-based oils and dried flower from the UK Medical Cannabis Registry

James Taita Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UKView further author information
,
Simon Erridgea Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK;b Department of Medicine, Sapphire Medical Clinics, London, UKCorrespondence[email protected]
View further author information
,
Carl Holveyb Department of Medicine, Sapphire Medical Clinics, London, UKView further author information
,
Ross Coomberb Department of Medicine, Sapphire Medical Clinics, London, UK;c Department of Trauma and Orthopaedics, St. George’s Hospital NHS Trust, London, UKView further author information
,
Azfer Usmanib Department of Medicine, Sapphire Medical Clinics, London, UK;d Department of Anaesthesia, Dartford and Gravesham NHS Trust, Kent, UKView further author information
,
Mohammed Sajadb Department of Medicine, Sapphire Medical Clinics, London, UK;e Department of Anaesthesia, Dudley Group of Hospitals NHS Trust, West Midlands, UKView further author information
,
Jonathan Hoarea Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK;b Department of Medicine, Sapphire Medical Clinics, London, UKView further author information
,
Shaheen Khanb Department of Medicine, Sapphire Medical Clinics, London, UK;f Department of Palliative Medicine, Guy’s and St. Thomas’ NHS Foundation Trust, London, UKView further author information
,
Mark Weatherallb Department of Medicine, Sapphire Medical Clinics, London, UK;g Department of Neurology, Buckinghamshire Healthcare NHS Trust, Amersham, UKView further author information
,
James J Ruckerb Department of Medicine, Sapphire Medical Clinics, London, UK;h Department of Psychological Medicine, King's College London, London, UK;i Centre for Affective Disorders, South London & Maudsley NHS Foundation Trust, London, UKView further author information
,
Michael Platta Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK;b Department of Medicine, Sapphire Medical Clinics, London, UKView further author information
&
Mikael H Sodergrena Imperial College Medical Cannabis Research Group, Department of Surgery and Cancer, Imperial College London, London, UK;b Department of Medicine, Sapphire Medical Clinics, London, UKORCID Iconhttps://orcid.org/0000-0002-7141-3924View further author information
ORCID Icon show all
Pages 413-423 | Received 04 Feb 2023, Accepted 22 Mar 2023, Published online: 06 Apr 2023

References

  • Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160(1):28–37. Cited: in: PMID: 30586068. DOI:10.1097/j.pain.0000000000001390
  • Fayaz A, Croft P, Langford RM, et al. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016;6(6):e010364. Cited: in: PMID: 27324708. DOI:10.1136/bmjopen-2015-010364.
  • Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082–2097.
  • Hylands-White N, Duarte RV, Raphael JH. An overview of treatment approaches for chronic pain management. Rheumatol Int. 2016 [[cited 2021 Oct 13]];Internet 37(1):29–42. DOI:10.1007/S00296-016-3481-8.
  • Huang W-J, Chen W-W, Zhang X. Endocannabinoid system: role in depression, reward and pain control (Review). Mol Med Rep. 2016 [[cited 2021 Oct 12]];InternetCited: in: PMID: 27484193 14(4):2899–2903. DOI:10.3892/MMR.2016.5585.
  • Maldonado R, Baños JE, Cabañero D. The endocannabinoid system and neuropathic pain. Pain. 2016;157(Supplement 1):S23–32. Cited in: PMID: 26785153.inoids DOI:10.1097/j.pain.0000000000000428.
  • Vučković S, Srebro D, Vujović KS, et al. Cannabinoids and pain: new insights from old molecules. Front Pharmacol. 2018;0:1259.
  • Pertwee RG. Handbook of cannabis. USA: Oxford University Press; 2014.
  • Anand U, Pacchetti B, Anand P, et al. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects. Pain Manag. 2021 Jul;11(4):395–403.
  • Kawka M, Erridge S, Holvey C, et al. Clinical outcome data of first cohort of chronic pain patients treated with cannabis-based sublingual oils in the United Kingdom: analysis from the UK Medical Cannabis Registry. J Clin Pharmacol. 2021 [[cited 2021 Oct 15]];2021:1–10. Internet DOI:10.1002/JCPH.1961
  • Wang L, Hong PJ, May C, et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. Cited: in: PMID: 34497047 2021;374:n1034. DOI:10.1136/bmj.n1034
  • Zeng L, Lytvyn L, Wang X, et al. Values and preferences towards medical cannabis among people living with chronic pain: a mixed-methods systematic review. BMJ Open. 2021 [[cited 2022 Jan 29]];11(9):e050831. InternetCited: in: PMID: 34493521. DOI:10.1136/BMJOPEN-2021-050831
  • Wilson P, Pangarkar S Cannabis in Medicine. In: Finn K, editor. Cannabis Med [Internet]. 1st ed. Springer International Publishing; 2020. p. 172–173,176. Available from: https://www.springer.com/gp/book/9783030459673.
  • Erridge S, Salazar O, Kawka M, et al. An initial analysis of the UK Medical Cannabis Registry: outcomes analysis of first 129 patients. Neuropsychopharmacol Reports. 2021;41(3):362–370. Cited: in: PMID: 33988306. DOI:10.1002/npr2.12183. .
  • Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*. Bull World Health Organ. 2007 [[accessed 2022 Mar 29]];InternetCited: in: PMID: 18038077 85(11):867. DOI:10.2471/BLT.07.045120.
  • BNF British National Formulary - NICE [Internet]. [accessed 2022 Mar 8]. Available from: https://bnf.nice.org.uk/?utm_source=evidencebnfredirect&utm_medium=other&utm_campaign=old_site_redirect.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis [Internet]. 1987 [cited 2022 Mar 8]; 40(5):373–383. Cited: in: PMID: 3558716. DOI:10.1016/0021-9681(87)90171-8.
  • ISCO - International Standard Classification of Occupations [Internet]. [cited 2022 Mar 11]. Available from: https://www.ilo.org/public/english/bureau/stat/isco/isco08/index.htm.
  • Tait J, Erridge S, Sodergren MH. UK Medical Cannabis Registry: a Patient Evaluation. J Pain Palliat Care Pharmacother. 2023 Jan 27;1–8. DOI:10.1080/15360288.2023.2174633.
  • Im DD, Jambaulikar GD, Kikut A, et al. Brief pain inventory–short form: a new method for assessing pain in the emergency department. Pain Med. 2020 [[cited 2022 Mar 10]];InternetCited: in: PMID: 32918473 21(12):3263–3269. DOI:10.1093/PM/PNAA269.
  • Dworkin RH, Turk DC, Revicki DA, et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 2009;144(1):35–42. Cited: in: PMID: 19356853. DOI:10.1016/j.pain.2009.02.007
  • Snyder E, Cai B, DeMuro C, et al. A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression. J Clin Sleep Med. 2018 [[cited 2022 Mar 10]];InternetCited: in: PMID: 30373688 14(11):1849. DOI:10.5664/JCSM.7478.
  • Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008 [[cited 2022 Mar 10]];InternetCited: in: PMID: 18388841 46(3):266–274. DOI:10.1097/MLR.0B013E318160D093.
  • Van Hout B, Janssen MF, Feng YS, et al. Interim Scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value Heal. 2012 [[cited 2022 Mar 10]];InternetCited: in: PMID: 22867780 15(5):708–715. DOI:10.1016/J.JVAL.2012.02.008.
  • Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 [[cited 2022 Mar 10]];InternetCited: in: PMID: 21479777 20(10):1727. DOI:10.1007/S11136-011-9903-X.
  • Position statement on use of the EQ-5D-5L value set for England (updated October 2019) | Technology appraisal guidance | NICE guidance | Our programmes | What we do | About | NICE [Internet]. [accessed 2022 Mar 10]. Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l.
  • Hurst H, Bolton J. Assessing the clinical significance of change scores recorded on subjective outcome measures. J Manipulative Physiol Ther. 2004 Jan 1;27(1):26–35.
  • Trotti A, Colevas AD, Setser A, et al. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol. 2007;25(32):5121–5127. Cited: in: PMID: 17991931. DOI:10.1200/JCO.2007.12.4784.
  • Abelev S, Warne LN, Benson M, et al. Medicinal cannabis for the treatment of chronic refractory pain: an investigation of the adverse event profile and health-related quality of life impact of an oral formulation. Med Cannabis Cannabinoids. 2022;5(1):1–12.
  • Gulbransen G, Xu W, Arroll B. Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. BJGP Open. 2020;4(1):1–8.
  • Romero-Sandoval EA, Kolano AL, Alvarado-Vázquez PA. Cannabis and cannabinoids for chronic pain. Curr Rheumatol Rep. 2017;19(11). Cited: in: PMID: 28983880. DOI:10.1007/s11926-017-0693-1
  • Goudman L, De Smedt A, Forget P, et al. Determining the minimal clinical important difference for medication quantification scale III and morphine milligram equivalents in patients with failed back surgery syndrome. J Clin Med. 2020 [[cited 2022 Feb 12]];Internet 99(11):3747–3747. DOI:10.3390/JCM9113747.
  • Noori A, Miroshnychenko A, Shergill Y, et al. Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies. BMJ Open. 2021 [[cited 2022 Mar 8]];11(7):47717. Internet. DOI:10.1136/bmjopen-2020-047717
  • Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ. 2010;182(14):E694–701. Cited: in: PMID: 20805210. DOI:10.1503/cmaj.091414.
  • Cooper ZD, Craft RM. Sex-dependent effects of cannabis and cannabinoids: a translational perspective. Neuropsychopharmacol Rev. 2018 [[cited 2022 Mar 31]];Internet 43(1):34–51. DOI:10.1038/npp.2017.140.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.